Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
Publication year
2021Author(s)
Source
Leukemia, 35, 6, (2021), pp. 1745-1750ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Haematology
Laboratory Medicine
Tumorimmunology
Journal title
Leukemia
Volume
vol. 35
Issue
iss. 6
Page start
p. 1745
Page end
p. 1750
Subject
Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Haematology - Radboud University Medical Center; Laboratory Medicine - Radboud University Medical Center; Tumorimmunology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [245103]
- Electronic publications [132420]
- Faculty of Medical Sciences [93207]
- Open Access publications [105998]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.